Skip to main content
. 2019 May 27;11(5):1193. doi: 10.3390/nu11051193

Table 2.

Comparison of clinical data between normal weight and overweight/obese women with fibromyalgia and healthy women.

Cases (n = 73) Controls (n = 73)
Normal (n = 17) Overweight/Obese (n = 56) p Value Normal (n = 21) Overweight/Obese (n = 52) p Value
VAS 6.93 ± 2.28 7.57 ± 1.59 0.499 1.93 ± 2.52 1.68 ± 2.73 0.650
TPC 17.80 ± 0.77 17.46 ± 1.41 0.590 1.33 ± 3.17 1.90 ± 3.72 0.257
FIQ-R
FIQ-R.1 16.82 ± 6.86 20.66 ± 4.71 0.030 - -
FIQ-R.2 11.60 ± 4.96 14.89 ± 4.43 0.059 - -
FIQ-R.3 35.20 ± 89.02 40.33. ± 5.60 0.033 - -
Total score 63.87 ± 19.12 75.94 ± 12.25 0.017 - -
Fatigue
MFI general fatigue 18.73 ± 1.28 18.15 ± 2.40 0.421 9.27 ± 4.51 9.50 ± 4.03 0.918
MFI physical fatigue 16.13 ± 3.06 16.61 ± 2.72 0.614 8.73 ± 4.75 9.60 ± 3.90 0.690
MFI mental fatigue 15.47 ± 1.45 15.24 ± 1.55 0.937 10.93 ± 2.12 11.57 ± 3.42 0.311
MFI reduced activity 13.47 ± 4.47 15.43 ± 3.64 0.150 7.87 ± 4.27 7.73 ± 4.29 0.984
MFI reduced motivation 14.00 ± 3.56 14.59 ± 3.48 0.566 8.40 ± 4.77 7.20 ± 2.68 0.253
Fatigue total score 77.80 ± 9.44 80.02 ± 9.61 0.449 45.20 ± 18.60 45.60 ± 14.22 0.939
Sleep Quality Index
Sleep quality 2.40 ± 0.73 2.35 ± 0.71 0.888 0.67 ± 0.57 2.00 ± 0.83 <0.001
Sleep latency 2.07 ± 1.10 2.46 ± 0.73 0.120 0.33 ± 0.57 2.00 ± 2.41 0.485
Sleep duration 2.27 ± 0.96 2.19 ± 0.79 0.785 1.00 ± 0.00 0.50 ± 0.70 0.357
Habitual sleep efficiency 2.07 ± 1.10 2.13 ± 1.05 0.972 0.33 ± 0.57 0.00 ± 0.00 0.969
Sleep disturbances 2.40 ± 0.50 2.26 ± 0.48 0.182 1.00 ± 0.00 1.50 ± 0.70 0.357
Sleeping medication 2.00 ± 1.36 2.08 ± 1.32 0.853 1.00 ± 1.73 0.50 ± 0.70 0.875
Daytime dysfunction 2.20 ± 0.67 2.35 ± 0.82 0.289 0.67 ± 0.57 0.50 ± 0.70 0.181
Global score 15.40 ± 4.30 15.95 ± 3.22 0.712 5.00 ± 3.60 6.00 ± 2.82 0.539
Anxiety 31.33 ± 1126 33.78 ± 9.35 0.441 11.33 ± 9.74 11.23 ± 11.07 0.893

VAS: visual analog scale, TPC: tender points count, FIQ-R: revised Fibromyalgia Impact Questionnaire, MFI: multidimensional fatigue inventory, FIQ-R.1: level of activity, FIQ-R.2: global impact, FIQ-R.3: symptoms intensity. Numerical variables are shown as mean ± SD.